Table 2 Associations between GV and in-hospital,30-day mortality in the logistic and Cox regression model.

From: Association between glycemic variability and mortality in critically ill patients with heart failure

Models

GV

GV quartiles

Total

(n = 23 744)

Q1

(n = 5 936)

Q2

(n = 5 936)

Q3

(n = 5 936)

Q4

(n = 5 936)

Inhospital mortality, OR (95% CI)

Model 1

3.82 (3.07, 4.75)

1.00 (Ref)

1.51 (1.35, 1.69)

1.81 (1.63, 2.02)

2.06 (1.85, 2.29)

Model 2

4.22 (3.38, 5.26)

1.00 (Ref)

1.52 (1.36, 1.71)

1.85 (1.66, 2.07)

2.16 (1.94, 2.41)

Model 3

4.50 (3.42, 5.92)

1.00 (Ref)

1.50 (1.31, 1.71)

1.79 (1.57, 2.04)

2.22 (1.94, 2.53)

Model 4

3.67 (2.77, 4.86)

1.00 (Ref)

1.43 (1.25, 1.64)

1.66 (1.45, 1.90)

2.02 (1.76, 2.31)

Model 5

3.21 (2.38, 4.33)

1.00 (Ref)

1.30 (1.13, 1.50)

1.44 (1.25, 1.66)

1.77 (1.54, 2.04)

30-day mortality, HR (95% CI)

Model 1

2.59 (2.17, 3.10)

1.00 (Ref)

1.29 (1.17, 1.41)

1.46 (1.33, 1.60)

1.61 (1.47, 1.76)

Model 2

2.85 (2.39, 3.40)

1.00 (Ref)

1.30 (1.18, 1.42)

1.49 (1.36, 1.63)

1.70 (1.56, 1.86)

Model 3

2.67 (2.18, 3.27)

1.00 (Ref)

1.27 (1.14, 1.41)

1.42 (1.28, 1.58)

1.64 (1.48, 1.82)

Model 4

2.21 (1.80, 2.72)

1.00 (Ref)

1.22 (1.09, 1.35)

1.31 (1.18, 1.45)

1.50 (1.35, 1.66)

Model 5

1.95 (1.58, 2.40)

1.00 (Ref)

1.13 (1.01, 1.25)

1.18 (1.07, 1.32)

1.37 (1.23, 1.52)

  1. Abbreviations: GV, glycemic variability; OR, odds ratio; CI, confidence interval; HR, hazard ratio; Ref, reference.
  2. Note: Model 1 adjusted for: none;.
  3. Model 2 adjusted for: covariates included in demographics;.
  4. Model 3 adjusted for: model 2 + covariates included in vital signs and comorbidities;.
  5. Model 4 adjusted for: model 3 + covariates included in laboratory tests;.
  6. Model 5 adjusted for: model 5 + covariates included in treatments.